Brenda Libby Coleman

Array ( [id] => 5416973 [patent_doc_number] => 20090042860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/184791 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18643 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042860.pdf [firstpage_image] =>[orig_patent_app_number] => 12184791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121788 [patent_doc_number] => 07709486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'CXCR4 antagonists' [patent_app_type] => utility [patent_app_number] => 12/182044 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 38 [patent_no_of_words] => 18526 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709486.pdf [firstpage_image] =>[orig_patent_app_number] => 12182044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270939 [patent_doc_number] => 20090074715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/180994 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78197 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074715.pdf [firstpage_image] =>[orig_patent_app_number] => 12180994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503690 [patent_doc_number] => 08034807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Salts of bazedoxifene' [patent_app_type] => utility [patent_app_number] => 12/670574 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3484 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034807.pdf [firstpage_image] =>[orig_patent_app_number] => 12670574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6551529 [patent_doc_number] => 20100222571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PROCESS FOR THE PREPARATION OF DROSPIRENONE' [patent_app_type] => utility [patent_app_number] => 12/670065 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10578 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222571.pdf [firstpage_image] =>[orig_patent_app_number] => 12670065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231653 [patent_doc_number] => 20100184744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHOD OF PREPARING A PHARMACEUTICAL CO-CRYSTAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/669779 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3250 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184744.pdf [firstpage_image] =>[orig_patent_app_number] => 12669779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104275 [patent_doc_number] => 08153786 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-04-10 [patent_title] => 'Synthesis of azido heterocycles' [patent_app_type] => utility [patent_app_number] => 12/173883 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2290 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153786.pdf [firstpage_image] =>[orig_patent_app_number] => 12173883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403018 [patent_doc_number] => 20100179319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE MIRTAZAPINE' [patent_app_type] => utility [patent_app_number] => 12/667969 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2825 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179319.pdf [firstpage_image] =>[orig_patent_app_number] => 12667969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860347 [patent_doc_number] => 20080269197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'AROMATIC SULFONES AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 12/144917 [patent_app_country] => US [patent_app_date] => 2008-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25518 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269197.pdf [firstpage_image] =>[orig_patent_app_number] => 12144917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887619 [patent_doc_number] => 20080261951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Condensed azepines as vasopressin agonists' [patent_app_type] => utility [patent_app_number] => 12/213651 [patent_app_country] => US [patent_app_date] => 2008-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7081 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261951.pdf [firstpage_image] =>[orig_patent_app_number] => 12213651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960601 [patent_doc_number] => 20080275026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Benzamide derivatives as oxytocin agonists and vasopressin antagonists' [patent_app_type] => utility [patent_app_number] => 12/213576 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18060 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275026.pdf [firstpage_image] =>[orig_patent_app_number] => 12213576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629454 [patent_doc_number] => 08008341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases' [patent_app_type] => utility [patent_app_number] => 12/142296 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16655 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008341.pdf [firstpage_image] =>[orig_patent_app_number] => 12142296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098479 [patent_doc_number] => 20110003984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'BISPIDON LIGANDS AND THE METAL COMPLEXES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/668784 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8422 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003984.pdf [firstpage_image] =>[orig_patent_app_number] => 12668784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6277002 [patent_doc_number] => 20100256358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Process for Preparing 4-Acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the Intermediates Thereof' [patent_app_type] => utility [patent_app_number] => 12/601962 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3427 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256358.pdf [firstpage_image] =>[orig_patent_app_number] => 12601962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571598 [patent_doc_number] => 20100234590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'PROCESS FOR THE PURIFICATION NE OF OLANZAPINE' [patent_app_type] => utility [patent_app_number] => 12/600009 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4821 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234590.pdf [firstpage_image] =>[orig_patent_app_number] => 12600009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522051 [patent_doc_number] => 20090030032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Bicyclic Compound, Production and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/119355 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62501 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030032.pdf [firstpage_image] =>[orig_patent_app_number] => 12119355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937445 [patent_doc_number] => 08987252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin' [patent_app_type] => utility [patent_app_number] => 12/598912 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50178 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12598912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248976 [patent_doc_number] => 20100137287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN' [patent_app_type] => utility [patent_app_number] => 12/598882 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48811 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137287.pdf [firstpage_image] =>[orig_patent_app_number] => 12598882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434483 [patent_doc_number] => 20100278878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'QUETIAPINE SALTS AND THEIR POLYMORPHS' [patent_app_type] => utility [patent_app_number] => 12/599085 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12271 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278878.pdf [firstpage_image] =>[orig_patent_app_number] => 12599085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550704 [patent_doc_number] => 08063037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Progesterone receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/115983 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14601 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063037.pdf [firstpage_image] =>[orig_patent_app_number] => 12115983 [rel_patent_id] =>[rel_patent_doc_number] =>)